Stock Earnings

Question 1

Regeneron Pharmaceuticals Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Regeneron Pharmaceuticals Inc의 총 자산은 $37,759이며, 순profit입니다.

Question 2

REGN의 주요 재무 비율은 무엇인가요?

Accepted Answer

Regeneron Pharmaceuticals Inc의 유동비율은 4.49이고, 순이익률은 31.06, 주당 매출은 $123.38입니다.

Question 3

Regeneron Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Currently Regeneron Pharmaceuticals Inc data is not available.

Question 4

Regeneron Pharmaceuticals Inc은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Regeneron Pharmaceuticals Inc의 순profit은 $4,412입니다.

Question 5

Regeneron Pharmaceuticals Inc에 부채가 있나요?

Accepted Answer

yes, Regeneron Pharmaceuticals Inc의 부채는 8,405입니다.

Question 6

Regeneron Pharmaceuticals Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Regeneron Pharmaceuticals Inc의 총 발행 주식은 109.6주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	14,247	14,202	13,117	12,172	16,071	8,497
Revenue Growth (YoY)	3%	8%	8%	-24%	89%	8%
Cost of Revenue	1,955	1,844	1,713	1,301	2,205	1,119
Gross Profit	12,292	12,357	11,403	10,871	13,865	7,377
Selling, General & Admin	3,196	2,954	2,631	2,115	1,824	1,441
Research & Development	5,156	5,132	4,439	3,592	2,864	2,650
Operating Expenses	8,358	8,139	7,068	5,618	4,643	3,810
Other Non Operating Income (Expenses)	38	15	-20	219	50	94
Pretax Income	5,145	4,779	4,199	4,858	9,325	3,810
Income Tax Expense	567	367	245	520	1,250	297
Net Income	4,578	4,412	3,953	4,338	8,075	3,513
Net Income Growth	-2%	12%	-9%	-46%	130%	66%
Shares Outstanding (Diluted)	107.2	115.1	113.7	113.5	112.2	115.1
Shares Change (YoY)	-8%	1%	0%	1%	-3%	0%
EPS (Diluted)	42.7	38.34	34.77	38.22	71.97	30.52
EPS Growth	7%	10%	-9%	-47%	136%	65%
Free Cash Flow	3,881	3,538	3,667	3,398	6,529	2,003
Free Cash Flow Per Share	36.2	30.73	32.25	29.93	58.19	17.4
Gross Margin	86.27%	87%	86.93%	89.31%	86.27%	86.81%
Operating Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Profit Margin	32.13%	31.06%	30.13%	35.63%	50.24%	41.34%
Free Cash Flow Margin	27.24%	24.91%	27.95%	27.91%	40.62%	23.57%
EBITDA	4,458	4,700	4,756	5,593	9,508	3,801
EBITDA Margin	31.29%	33.09%	36.25%	45.94%	59.16%	44.73%
D&A For EBITDA	525	482	421	341	286	235
EBIT	3,933	4,218	4,335	5,252	9,222	3,566
EBIT Margin	27.6%	29.7%	33.04%	43.14%	57.38%	41.96%
Effective Tax Rate	11.02%	7.67%	5.83%	10.7%	13.4%	7.79%

Regeneron Pharmaceuticals Inc (REGN) Price